8-KEarnings & ResultsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Financial Results (Jul 26, 2018)

Filed July 26, 2018For Securities:EW

Summary

Edwards Lifesciences Corporation (EW) filed an 8-K on July 26, 2018, to report its financial results for the second quarter of 2018. This filing primarily consists of a press release detailing the company's performance during the period. Investors should focus on the information presented in the furnished press release (Exhibit 99.1) for specific financial metrics and operational updates, as this is the core of the report's substance. The 8-K itself is a notification mechanism, with the detailed financial data being contained within the supplemental materials.

Key Highlights

  • 1The 8-K filing announces Edwards Lifesciences' (EW) second-quarter 2018 financial results.
  • 2The primary disclosure vehicle for the Q2 2018 results is a press release furnished as Exhibit 99.1.
  • 3The press release contains the company's detailed financial performance for the second quarter of 2018.
  • 4This filing does not contain any new material events beyond the release of Q2 financial results.
  • 5Investors should review Exhibit 99.1 for specific revenue, earnings, and operational metrics.
  • 6The information is furnished, not filed, under the Securities Exchange Act of 1934.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and provide access to Edwards Lifesciences' financial results for the second quarter of 2018 through an accompanying press release.

The detailed financial results for the second quarter of 2018 are contained within the press release furnished as Exhibit 99.1 to this 8-K filing.

No, this 8-K filing is solely focused on the reporting of the company's second-quarter 2018 financial and operational results as presented in the press release. It does not disclose any new material events beyond these financial disclosures.

When information is furnished under Item 2.02, it means it is being provided to the SEC but is not subject to the same liabilities as information that is 'filed.' While it's for public disclosure, it doesn't carry the same legal implications under the Securities Exchange Act of 1934.